UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Amgen Europe B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6d7c47479e6e2024
Drug Cima Aemps Name: UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211602001
Holder Company Name: Amgen Europe B.V.
Marketing Company Name: Amgen S.A.
Holder Company Detail Path: /organization/amgen-europe-b-v
Marketing Company Detail Path: /organization/amgen-sa
Authorization Date: 2022-07-22
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 10 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Amgen Europe B.V.
Company Detail Path: /organization/amgen-europe-b-v

INEBILIZUMAB

10 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 22, 2022

Approval ID

6d7c47479e6e2024

Type

Standard